Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Transfusion of red blood cells (RBCs) is a standard and indispensable therapy in current clinical practice. In vitro production of RBCs offers a potential means to overcome a shortage of transfusable RBCs in some clinical situations and also to provide a source of cells free from possible infection or contamination by microorganisms. Thus, in vitro production of RBCs may become a standard procedure in the future. We previously reported the successful establishment of immortalized mouse erythroid progenitor cell lines that were able to produce mature RBCs very efficiently. Here, we have developed a reliable protocol for establishing immortalized human erythroid progenitor cell lines that are able to produce enucleated RBCs. These immortalized cell lines produce functional hemoglobin and express erythroid-specific markers, and these markers are upregulated following induction of differentiation in vitro. Most importantly, these immortalized cell lines all produce enucleated RBCs after induction of differentiation in vitro, although the efficiency of producing enucleated RBCs remains to be improved further. To the best of our knowledge, this is the first demonstration of the feasibility of using immortalized human erythroid progenitor cell lines as an ex vivo source for production of enucleated RBCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Gene expression profiles of the established erythroid progenitor cell lines estimated by quantitative RT-PCR analysis. Analyzed genes are indicated. FL, results with cDNA derived from human fetal liver. Relative expression was evaluated compared to that of FL. CB, cord blood. CB 6, 10 and 16, results with cDNA derived from cultured erythroid cells, i.e., CD34-positive cells in CB were induced to differentiate into mature erythroid cells for 6, 10 and 16 days, respectively, using the previously reported method [4]. B and A, Before and 2 days after induction of differentiation of HiDEP and HUDEP cells.](https://figures.cochat.ai/paper-figures/2c1a4cd9be89480c8e81cf1b067b0b83/establishment-of-immortalized-human-erythroid-progenitor-cell-lines-able-to-figure-7.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, overexpression of CBL and CNN1 transgenes in a human erythroid progenitor model (HUDEP2 cells) individually and in combination also induced markers of erythroid differentiation (Fig. 3F–G and fig. S10C–D) (21).”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodTranscriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodHuman Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
Robb, L., Lyons, I., Li, R., Hartley, L., Köntgen, F., Harvey, R. P., Metcalf, D., & Begley, C. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7075 · Cited by 577 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundDevelopmental and species-divergent globin switching are driven by BCL11A
Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., et al. (2009) · Nature · doi:10.1038/nature08243 · Cited by 379 · cited 1×
“Of note, BCL11A, a repressor of c-globin expression [25] and critical mediator of globin switching [26], was abundantly detected only in the HUDEP-2 cell line in which b-globin was up-regulated after differentiation (Figure 7).”
BackgroundMikkola, H. K. A., Klintman, J., Yang, H., Hock, H., Schlaeger, T. M., Fujiwara, Y., & Orkin, S. H. (2003) · Nature · doi:10.1038/nature01345 · Cited by 371 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundProof of principle for transfusion of in vitro–generated red blood cells
Giarratana, M.-C., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Le Pennec, P.-Y., François, S., Trugnan, G., Peyrard, T., Marie, T., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362038 · Cited by 342
KARASAWA, S., ARAKI, T., NAGAI, T., MIZUNO, H., & MIYAWAKI, A. (2004) · Biochemical Journal · doi:10.1042/bj20040321 · Cited by 342 · cited 1×
“The CSIV-TRE-RfA-UbC-KT lentiviral vector plasmid (Figure S2) contains the humanized Kusabira-Orange 1 (hKO1) fluorescent protein gene [11] and the reverse tetracycline (Tet)-controlled transcriptional transactivator (TAKARA BIO) linked by the Thosea asigna virus 2A peptide sequence under the control of human ubiquiti…”
BackgroundBiologic properties and enucleation of red blood cells from human embryonic stem cells
Lu, S.-J., Feng, Q., Park, J. S., Vida, L., Lee, B.-S., Strausbauch, M., Wettstein, P. J., Honig, G. R., & Lanza, R. (2008) · Blood · doi:10.1182/blood-2008-05-157198 · Cited by 293 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
Background
Cited by
Items 201–300 of 418
Yang, H. M., Zheng, G., Li, G. Y., Alshaye, A., & Orkin, S. H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108077 · Cited by 12
“As assessed by expression of HA-tagged constructs in HUDEP2 cells (15), a human umbilical cord-derived erythroid progenitor cell line, TRIM10 appeared to localize to both cell membrane and cytoplasm, while TRIM58 was predominantly cytoplasmic (Fig.”
Chu, S. N., Soupène, E., Sharma, D., Sinha, R., McCreary, T., Hernandez, B. N., Shen, H., Wienert, B., Bowman, C., Yin, H., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115141 · Cited by 17
“To determine cleavage frequencies, we delivered candidate gRNAs pre-complexed with Cas9 protein to the human HUDEP-2 cell line 16 via transfection.”
Regulation of eIF4E guides a unique translational program to control erythroid maturation
Forester, C. M., Osés-Prieto, J. A., Phillips, N. J., Miglani, S., Pang, X., Byeon, G. W., Demarco, R., Burlingame, A. L., Barna, M., & Ruggero, D. (2022) · Science Advances · doi:10.1126/sciadv.add3942 · Cited by 11
“To test our hypothesis, we used HUDEP-2 cells, a human cord blood – derived, nontransformed cell line capable of expanding as early precursors and differentiating into mature erythroid cells ( 25 ).”
Yang, X., Li, C., Ye, X., Zhang, J., Chen, X., Xu, J., Zhang, M., Feng, R., Hyle, J. W., Qi, W., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03510-z · Cited by 12
“In this study, we established the auxin-inducible degradation (AID) system as CTCF-AID knockin in two human erythroid cell lines, HUDEP-2 and HEL, which are well-known cellular models for studying erythroid gene expression and differentiation [15, 16] .”
A genome-wide screen identifies genes required for erythroid differentiation
Myers, G., Friedman, A. D., Yu, L., Pourmandi, N., Kerpet, C., Ito, M. A., Saba, R., Tang, V. T., Ozel, A. B., Bergin, I. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58739-w · Cited by 14
“The HUDEP-2 cell line was a gift from Y. Nakamura 26 .”
Self-citationJunker, L. H., Li, Y., Zhu, X., Koti, S., Cerbone, R. E., Hendrick, C. L., Sangerman, J., Perrine, S. P., & Pace, B. S. (2021) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2021.102626 · Cited by 12
Bircher, C., Bieri, J., Assaraf, R., Leisi, R., & Ros, C. (2022) · Viruses · doi:10.3390/v14020420 · Cited by 10
“These cells express erythroid-specific markers, which are upregulated after the induction of differentiation [41].”
BackgroundInfluentialZhou, G., Zhang, H., Lin, A., Wu, Z., Li, T., Zhang, X., Chen, H., & Lu, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052807 · Cited by 11
“Here, we constructed an HUDEP2 cell line with a homozygous knockout of the HBB gene [34].”
MethodInfluentialThe challenge of growing enough reticulocytes for transfusion
Severn, C. E., & Toye, A. M. (2017) · ISBT Science Series · doi:10.1111/voxs.12374 · Cited by 15
Lourenço, S. P., Jarocha, D. J., Ghiaccio, V., Guerra, A., Abdulmalik, O. Y., La, P., Zezulin, A. U., Smith‐Whitley, K., Kwiatkowski, J. L., Guzikowski, V., et al. (2021) · Haematologica · doi:10.3324/haematol.2020.276634 · Cited by 10
Self-citationWonkam, A., Esoh, K. K., Levine, R. M., Bitoungui, V. J. N., Mnika, K., Nimmagadda, N., Dempsey, E., Nkya, S. W., Sangeda, R. Z., Nembaware, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57413-5 · Cited by 12
“Twelve microliters of each PCR reaction were added to one well of a 96-well QIAcuity digital PCR plate, 8500 partitions per sample (Qiagen).”
InfluentialClonal hematopoiesis landscape in frequent blood donors
Karpova, D., Encabo, H. H., Donato, E., Calderazzo, S., Scherer, M., Llorian, M., Leppä, A., Würth, R., Stelmach, P., Papazoglou, D., et al. (2025) · Blood · doi:10.1182/blood.2024027999 · Cited by 18
Modelling human haemoglobin switching
Diepstraten, S. T., & Hart, A. H. (2018) · Blood Reviews · doi:10.1016/j.blre.2018.06.001 · Cited by 14
Hemoglobin switching in mice carrying the Klf1Nan variant
Korporaal, A. L., Gillemans, N., Heshusius, S., Cantú, I., van den Akker, E., van Dijk, T. B., Lindern, M. V., & Philipsen, S. (2020) · Haematologica · doi:10.3324/haematol.2019.239830 · Cited by 10
Induction of enucleation in primary and immortalized erythroid cells
Soboleva, S., & Miharada, K. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03386-w · Cited by 9
“Erythroid cell lines can be established from various cell origins; we have established multiple cell lines by immortalizing human erythroid progenitor cells differentiated from UCB CD34+ cells and human iPS cells with human papillomavirus E6/E7 gene (HPV-E6/E7) [65].”
BackgroundSelf-citationEffect of Induced Pluripotent Stem Cell Technology in Blood Banking
Focosi, D., & Pistello, M. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0257 · Cited by 10
Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs
Ijee, S., Chambayil, K., Chaudhury, A. D., Bagchi, A., Modak, K., Das, S., Benjamin, E. S. B., Rani, S., Paul, D. Z., Nath, A., et al. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1295507 · Cited by 10
Self-citationVariable characteristics overlooked in human K-562 leukemia cell lines with a common signature
Kasai, F., Mizukoshi, K., & Nakamura, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-60271-8 · Cited by 13
“In contrast, another human erythroid progenitor cell line, HUDEP-2 (RCB4557) 33 , expresses adult-type hemoglobin and is therefore widely used for various studies.”
BackgroundSelf-citationHorton, J. R., Yu, M., Zhou, J., Tran, M. L., Anakal, R. R., Lu, Y., Blumenthal, R., Zhang, X., Huang, Y., Zhang, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58998-7 · Cited by 12
“To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/ 1”
InfluentialDemers, M., Sturtevant, S., Guertin, K. R., Gupta, D., Desai, K., Vieira, B. F., Li, W., Hicks, A., Ismail, A., Gonçalves, B. P., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003670 · Cited by 10
Satchwell, T. J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1039520 · Cited by 9
“, 2020), current literature suggests this adult bone marrow derived erythroblast line to give the greatest reticulocyte yield amongst similar equivalents (Kurita et al., 2013; Kurita et al., 2019; Scully et al., 2019; Daniels et al., 2020).”
BackgroundChaand, M., Fiore, C., Johnston, B., D’Ippolito, A. M., Moon, D. H., Carulli, J. P., & Shearstone, J. R. (2023) · Communications Biology · doi:10.1038/s42003-023-05025-4 · Cited by 10
“HUDEP-1 and HUDEP-2 16 cells were purchased under a licensing agreement from RIKEN BioResource Research Center, Japan.”
InfluentialDevelopment of platelet replacement therapy using human induced pluripotent stem cells
Nakamura, S., Sugimoto, N., & Eto, K. (2021) · Development Growth & Differentiation · doi:10.1111/dgd.12711 · Cited by 10
“…blood cells, such as lymphocytes (Nishimura et al., 2013; Themeli et al., 2013; Vizcardo et al., 2013), myeloid cells (Haruta et al., 2013), erythrocytes (Hirose et al., 2013; Kurita et al., 2013), and platelets, has been successfully achieved, and attempts for clinical applications are underway.”
BackgroundSoboleva, S., Kurita, R., Ek, F., Åkerstrand, H., Silvério-Alves, R., Olsson, R., Nakamura, Y., & Miharada, K. (2021) · Communications Biology · doi:10.1038/s42003-021-02202-1 · Cited by 9
Self-citationHatta, S., Fujiwara, T., Yamamoto, T., Saito, K., Kamata, M., Tamai, Y., Kawamata, S., & Harigae, H. (2018) · Haematologica · doi:10.3324/haematol.2017.179770 · Cited by 10
“One potential limitation of the present protocol is that only a subset of the XiPS cell-derived erythroblasts (approximately 20%) exhibited ring sideroblasts, a problem which may be overcome by establishing an immortalized erythroblast clone with ring sideroblasts based on viral transduction of the hematopoietic trans…”
BackgroundOmics Studies in Hemoglobinopathies
Katsantoni, E. Z. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00386-1 · Cited by 10
Lanza, F., & Seghatchian, J. (2020) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2020.102941 · Cited by 9
“Nakamura’s laboratory developed cell lines able to produce enucleated RBCs (though at a low efficiency) with functional Hb after differentiation in vitro [21].”
The role of glucocorticoids in erythropoiesis
Hanssen, L. L. P., & Iskander, D. (2025) · Frontiers in Hematology · doi:10.3389/frhem.2025.1540152 · Cited by 11
Ping, J., Liu, X., Lu, Y., Quan, C., Fan, P., Lu, H., Li, Q., Wang, C., Zhang, Z., Liu, M., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100782 · Cited by 9
“…progenitor 2 (HUDEP2) cell, which is an immortalized CD34 + hematopoietic stem and progenitor cells (HSPCs)-derived erythroid progenitor cell line, 59 was expanded in serum-free medium (Stem Cell Technologies, Vancouver, Canada) supplied with doxycycline (1 m g/mL), dexamethasone (10 –6 M), stem…”
Bagchi, A., Devaraju, N., Chambayil, K., Rajendiran, V., Venkatesan, V., Sayed, N., Pai, A. A., Nath, A., David, E. K., Nakamura, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-13783-0 · Cited by 9
Self-citationPrasad, K. M., Devaraju, N., George, A., Ravi, N. S., Paul, J., Mahalingam, G., Rajendiran, V., Panigrahi, L., Venkatesan, V., Lakhotiya, K., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102205 · Cited by 11
“29 For the primary screening, we generated HUDEP-2 cells with a spectrum of b -thalassemia mutations (Figure 1A), as it is often challenging to obtain a b -thalassemia patient CD34+ HSPCs with particular point mutations.”
Self-citationMayers, S. J., Moço, P. D., Maqbool, T., Silva, P. N., Kilkenny, D. M., & Audet, J. (2019) · BMC Biotechnology · doi:10.1186/s12896-019-0515-9 · Cited by 6
Boddu, P. C., Gupta, A. K., Kim, J.-S., Neugebauer, K. M., Waldman, T. A., & Pillai, M. M. (2021) · Communications Biology · doi:10.1038/s42003-021-02690-1 · Cited by 8
Therapeutic use of Red Blood Cells and Platelets Derived from Human Cord Blood Stem Cells
Xie, X., Yao, H., Han, X., Yue, W., & Pei, X. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0517 · Cited by 8
“Researchers are also devoted to generating immortalized erythroid and megakaryocytic progenitors for continuous blood cell expansion and generation.(20,21) Patients harboring minor blood group antigens or alloimmunity against HLA class I molecules are usually refractory to standard blood products.”
BackgroundSoboleva, S., Kurita, R., Kajitani, N., Åkerstrand, H., & Miharada, K. (2021) · Human Cell · doi:10.1007/s13577-021-00652-7 · Cited by 8
“However, in the case of two cell lines, we have previously generated (Human Umbilical Cord Blood-Derived Erythroid Progenitor: HUDEP, and Human iPS cell-Derived Erythroid Progenitor: HiDEP) [5], the termination of HPVE6/E7 gene by removing doxycycline significantly reduced cell viability and the resulting yield of enu…”
InfluentialSelf-citationLi, J., Zhou, Z., Sun, H., Ouyang, W., Dong, G., Liu, T., Ge, L., Zhang, X., Liu, C., & Gu, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.577053 · Cited by 8
Establishment of a cell model of X-linked sideroblastic anemia using genome editing
Kaneko, K., Kubota, Y., Nomura, K., Hayashimoto, H., Chida, T., Yoshino, N., Wayama, M., Ogasawara, K., Nakamura, Y., Tooyama, I., et al. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.06.002 · Cited by 8
Self-citationKikuchi, G., Kurita, R., Ogasawara, K., Isa, K., Tsuneyama, H., Nakamura, Y., Yabe, R., Shiba, M., Tadokoro, K., Nagai, T., et al. (2018) · Transfusion · doi:10.1111/trf.14840 · Cited by 9
“In contrast, immortalized human-induced pluripotent stem cell– derived erythroid progenitor (HiDEP) cell lines can constitutively synthesize Hb, and these cells are deep red in color, even before differentiation.(12) Therefore, HiDEP cell lines are expected to be a novel source of cells for the generation of reagent R…”
BackgroundSelf-citationXu, S., Liang, D., Wang, Q., Cheng, Y., Xie, D., Yang, G., Zhang, H., Feng, C., Zhao, F., Ren, W., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.28.620445 · Cited by 8
Stephanou, C., Menzel, S., Philipsen, S., & Kountouris, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111408 · Cited by 9
“Notably, the use of immortalized human erythroid progenitor cells first reported in 2013 as a model for adult erythropoiesis [78], has been instrumental for the success of CRISPR/Cas-mediated genetic screens aimed at elucidation of the in cis and in trans HbF regulatory network.”
BackgroundMazzarini, M., Cherone, J. M., Nguyen, T., Martelli, F., Varricchio, L., Funnell, A. P. W., Papayannopoulou, T., & Migliaccio, A. R. (2024) · Stem Cells · doi:10.1093/stmcls/sxae049 · Cited by 6
Ferguson, D. C. J., Mokim, J. H., Meinders, M., Moody, E. R. R., Williams, T. A., Cooke, S., Trakarnsanga, K., Daniels, D. E., Vicens, I. F., Shoemark, D. K., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.256347 · Cited by 8
“Overexpression of ZNF648 in erythroid cells reduces proliferation and advances differentiation In order to begin to explore the role of ZNF648 in erythropoiesis we initially expressed exogenous ZNF648 in HiDEP-1 cells, an erythroid cell line created by immortalising erythroid cells differentiated from iPSC.(38) HiDEP-…”
BackgroundHan, Y., Wang, S., Wang, Y., Huang, Y., Gao, C., Guo, X., Chen, L., Zhao, H., & An, X. (2023) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2023.07.001 · Cited by 7
“The enucleation rate of OrthoEs derived from ES cells, induced pluripotent stem cells, or immortalized erythroid cells is usually very low [13,30,45,46].”
BackgroundMethodInfluentialDevelopment of autologous blood cell therapies
Kim, A. R., & Sankaran, V. G. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.06.005 · Cited by 9
Makino, T., Haruyama, M., Katayama, K., Terashima, H., Tsunemi, T., Miyazaki, K., Terakawa, M., Yamashiro, K., Yoshioka, R., & Maeda, H. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113717 · Cited by 8
SCAR : The high‐prevalence antigen 013.008 in the Scianna blood group system
Srivastava, K., Albasri, J., Alsuhaibani, O. M., Aljasem, H. A., Bueno, M. U., Antonacci, T., Branch, D. R., Denomme, G. A., & Flegel, W. A. (2020) · Transfusion · doi:10.1111/trf.16152 · Cited by 7
Baik, R., Wyman, S. K., Kabir, S., & Corn, J. E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247858 · Cited by 8
“There was no difference in the fraction of cells expressing CD71 based on JAK2 editing (V617F 70.4% CD71+ and V617V 65.6% CD71+).”
BackgroundMethodInfluentialLiu, Q., Li, X., Xu, H., Luo, Y., Cheng, L., Liang, J., He, Y., Liu, H., Fang, J., & Huang, J. (2025) · Advanced Biotechnology · doi:10.1007/s44307-024-00053-5 · Cited by 6
“The HUDEP-2 cells (Kurita et al. 2013) were cultured in StemSpan Serum-Free Expansion Medium (SFEM, Stemcell Technologies) supplemented with 1% Penicil-lin–Streptomycin solution (10,000 U/mL stock), 50 ng/ mL recombinant human stem cell factor (SCF, Pepro-tech), 3 IU/mL Epoetin alfa (Epogen,…”
The non-canonical poly(A) polymerase FAM46C promotes erythropoiesis
Yang, K., Zhu, T., Yin, J., Zhang, Q., Li, J. Y., Fan, H., Han, G., Xu, W., Liu, N., & Lv, X. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.02.003 · Cited by 7
Hassan, H., & Rajput, S. K. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2024.1373408 · Cited by 8
Martyn, G. E., Doerfler, P. A., Yao, Y., Quinlan, K. G. R., Weiss, M. J., & Crossley, M. (2024) · Journal of sickle cell disease. · doi:10.1093/jscdis/yoae008 · Cited by 10
Katayama, K., Tsunemi, T., Miyazaki, K., Uoto, K., Yoshioka, R., Terashima, H., Terakawa, M., Yamashiro, K., Haruyama, M., Maeda, H., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127425 · Cited by 7
Zurlo, M., Gasparello, J., Cosenza, L. C., Breveglieri, G., Papi, C., Zuccato, C., Gambari, R., & Finotti, A. (2023) · Genes · doi:10.3390/genes14030556 · Cited by 6
“In particular, the HUDEP-2 cell line is of relevant interest, since, unlike K562 cells, its cells express predominantly adult β-globin and most closely resemble adult erythroid cells [32].”
BackgroundGnanapragasam, M. N., Planutis, A., Glassberg, J., & Bieker, J. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-34805-5 · Cited by 7
Cellular and animal models for the investigation of β-thalassemia
Nai, A., Cordero-Sánchez, C., Tanzi, E., Pagani, A., Silvestri, L., & Modica, S. M. D. (2023) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2023.102761 · Cited by 7
Durlak, M., Fugazza, C., Elangovan, S., Marini, M. G., Marongiu, M. F., Moi, P., Fraietta, I., Cappella, P., Barbarani, G., Font-Monclus, I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141083 · Cited by 8
“Recently established IPs-derived immortalized cell lines [27] represent a very promising tool for similar studies, but we feel that the easiness of growth and manipulation of β-K562 still represent a valuable advantage.”
ResultEl‐Badry, M., Espinoza, J. L., & Nakao, S. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2016.12.011 · Cited by 7
Ito, S., Kaito, S., Miyazaki, T., Kikuchi, G., Isa, K., Tsuneyama, H., Kurita, R., Ogasawara, K., Uchikawa, M., & Satake, M. (2020) · Transfusion · doi:10.1111/trf.15828 · Cited by 6
Self-citationGuerra, A., Musallam, K. M., Taher, A. T., & Rivella, S. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.002 · Cited by 7
Papaioannou, N. Y., Patsali, P., Naiisseh, B., Papasavva, P. L., Koniali, L., Kurita, R., Nakamura, Y., Christou, S., Sitarou, M., Mussolino, C., et al. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1141618 · Cited by 6
“Here, we present a detailed highly efficient in vitro transcription protocol based on the NEB HiScribeTM T7 ARCA mRNA kit with tailing, for production of editors as mRNA from plasmid DNA, and the delivery of these tools in hematopoietic cells, including the human umbilical cord-blood derived erythroid progenitor (HUDE…”
MethodSelf-citationVerheul, T. C. J., Gillemans, N., Putzker, K., Majied, R., Li, T., Vasiliou, M., Eussen, B., de Klein, A., van IJcken, W. F. J., van den Akker, E., et al. (2024) · HemaSphere · doi:10.1002/hem3.139 · Cited by 6
“HBG1 was then targeted in the fetal ‐ like HUDEP1 cells 19 to test the feasibility of CRISPR ‐ Cas9 ‐ mediated tagging of HBG1 .”
BackgroundMethodInfluentialSelf-citationShao, C., Liu, Q. F., Xu, J., Zhang, J.-X., Zhang, C., Ye, X., Ye, Y., Lin, B., Zhang, X., Cheng, L., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102371 · Cited by 6
How Far Are Stem-Cell-Derived Erythrocytes from the Clinical Arena?
Li, X., Wu, Z., Fu, X., & Han, W. (2013) · BioScience · doi:10.1525/bio.2013.63.8.6 · Cited by 5
“…the transcription factor stem cell leukemia/Tcell acute lymphoblastic leukemia 1 (which plays essential roles in early hematopoiesis and dif ferentiation of erythroid cells and megakaryocytes) in order to boost the rate of production of hematopoietic cells, espe cially RBCs (Kurita et al. 2013).”
BackgroundTransglutaminase 2 regulates terminal erythroid differentiation via cross-linking activity
Zhang, Y., Shi, L., Yang, K. G., Liu, X., & Lv, X. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1183176 · Cited by 5
“, 1976), as well as HUDEP2 (Kurita et al., 2013)and MEL (Scher et al.”
BackgroundEx Vivo Production of Platelets From iPSCs: The iPLAT1 Study and Beyond
Sugimoto, N., & Eto, K. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000884 · Cited by 6
Zurlo, M., Gasparello, J., Verona, M., Papi, C., Cosenza, L. C., Finotti, A., Marzaro, G., & Gambari, R. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113853 · Cited by 6
Wang, E., Liu, S., Zhang, X., Peng, Q., Yu, H., Gao, L., Xie, A., Ma, D., Zhao, G., & Cheng, L. (2024) · Advanced Science · doi:10.1002/advs.202303471 · Cited by 5
Stem cell factor and erythropoietin-independent production of cultured reticulocytes
Olivier, E. N., Zhang, S., Yan, Z., & Bouhassira, E. E. (2024) · Haematologica · doi:10.3324/haematol.2023.284427 · Cited by 5
Marothia, M., Behl, A., Maurya, P., Saini, M., Shoaib, R., Garg, S., Kumari, G., Biswas, S., Munjal, A., Anand, S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109918 · Cited by 5
RetractedExpandable progenitors from induced pluripotent stem cells
Masuda, S., Miyagawa, S., Fukushima, S., Nakamura, T., Khurram, M. A., Ishikawa, T., Saito, A., & Sawa, Y. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.129 · Cited by 5
Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2
George, A., Ravi, N. S., Prasad, K. M., Panigrahi, L., Koikkara, S., Rajendiran, V., Devaraju, N., Paul, J., Pai, A. A., Nakamura, Y., et al. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.1085111 · Cited by 8
“supplemented with 10% FBS and 1x Penicillin Streptomycin HUDEP2 cells were cultured in StemSpanTM SFEM II (STEMCELL Technologies) supplemented with 50 ng/ml SCF (ImmunoTools), 3 U/ml EPO (Zyrop 4000 IU Injection), 1x Pen-Strep, 1 μM dexamethasone (Alfa Aesar), 1 μg/ml doxycycline (Sigma-Aldrich) and 1x L-Glutamine 200…”
MethodSelf-citationTranscriptional repression of the oncofetal LIN28B gene by the transcription factor SOX6
Pastori, V., Zambanini, G., Citterio, E., Weiss, T., Nakamura, Y., Cantù, C., & Ronchi, A. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-60438-3 · Cited by 5
“Lin28B and Sox6 expression profiles, both at the mRNA and protein level, also inversely correlate in human HUDEP1 and HUDEP2 cells 47 , representative of embryo/fetal and adult erythropoiesis, respectively (Fig.”
Self-citationKronstein‐Wiedemann, R., Thiel, J., Sürün, D., Teichert, M., Künzel, S. R., Zimmermann, S., Wagenführ, L., Buchholz, F., & Tonn, T. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.06.009 · Cited by 4
Yang, J.-P., Toughiri, R., Gounder, A. P., Scheibe, D., Petrus, M. J., Fink, S. J., Vallée, S., Kenniston, J. A., Papaioannou, N., Langston, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307049 · Cited by 5
Long, Y., Zhang, Q., Ling, L., Zhuang, Y., Wei, X., Huang, H., Lu, Z., Huang, Y., Chen, X., Ye, Y., et al. (2024) · Blood · doi:10.1182/blood.2023022688 · Cited by 9
Self-citationFelder, A.-K., Tjalsma, S. J. D., Verhagen, H. J. M. P., Majied, R., Verstegen, M. J. A. M., Verheul, T. C. J., van Haren, J., Mohnani, R., Gremmen, R., Krijger, P. H. L., et al. (2025) · Blood · doi:10.1182/blood.2024028128 · Cited by 8
High level of fetal-globin reactivation by designed transcriptional activator-like effector
Zhan, J., Irudayam, M. J., Nakamura, Y., Kurita, R., & Nienhuis, A. W. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000482 · Cited by 4
“Human umbilical cord blood derived erythroid progenitor cell culture Human umbilical cord blood derived erythroid progenitor (HUDEP) clone 2 (HUDEP-2) cells were cultured as previously described.(25) Briefly, cells were expanded in StemSpan SFEM”
MethodSelf-citationEngineering of the endogenous HBD promoter increases HbA2
Boontanrart, M. Y., Mächler, E., Ponta, S., Nelis, J. C., Preiano, V. G., & Corn, J. E. (2023) · eLife · doi:10.7554/elife.85258 · Cited by 4
“We performed editing in HUDEP-2 cells, an immortalized cell line capable of differentiating into hemoglobin-producing erythroid cells Kurita et al., 2013 , using Cas9 ribonucleoprotein (RNP) and an ssODN.”
TR4 and BCL11A repress γ-globin transcription via independent mechanisms
Wang, Y., Myers, G., Yu, L., Deng, K., Balbin-Cuesta, G., Singh, S. A., Guan, Y., Khoriaty, R. N., & Engel, J. D. (2024) · Blood · doi:10.1182/blood.2024024599 · Cited by 5
Improvement of Red Blood Cell Maturation In Vitro by Serum-Free Medium Optimization
Kim, S. H., Lee, E. M., Han, S. Y., Choi, H. S., Ryu, K. Y., & Baek, E. J. (2019) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2019.0023 · Cited by 4
CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cellsPreprint
Chung, J. E., Magis, W., Vu, J. T., Heo, S., Wartiovaara, K., Walters, M. C., Kurita, R., Nakamura, Y., Boffelli, D., Martin, D. I. K., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/335729 · Cited by 4
Self-citationSeghatchian, J. (2020) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2020.102862 · Cited by 4
ZNF410 uniquely activates the NuRD component CHD4 to silence fetal hemoglobin expressionPreprint
Lan, X., Ren, R., Feng, R., Ly, L. C., Lan, Y., Zhang, Z., Aboreden, N. G., Qin, K., Horton, J. R., Grevet, J. D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.31.274324 · Cited by 4
Hara, Y., Kawabata, E., Lemgart, V. T., Bronson, P. G., Hicks, A., Peters, R., Krishnamoorthy, S., Ribeil, J., Schmunk, L. J., Eglinton, J., et al. (2023) · medRxiv · doi:10.1101/2023.03.14.23287244 · Cited by 4
A non-IMiD multi-target degrader reactivates fetal hemoglobin
Liu, J., Shen, Z., Park, S., Dong, Y., Yu, N., Zeng, J., Lee, H., Pate, B., Adamia, S., Vanuytsel, K., et al. (2026) · Experimental Hematology and Oncology · doi:10.1101/2025.09.17.676148 · Cited by 4
BMI1 regulates human erythroid self-renewal through both gene repression and gene activation
McGrath, K. E., Olsen, J., Koniski, A. D., Murphy, K. E., Getman, M. R., An, H. H., Schulz, V., Kim, A. R., Zhang, B., Carlson, T. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62993-3 · Cited by 4
“%) rates of enucleation 49 – 52 .”
Direct and indirect regulation of fetal globin transcript by the RNA-binding protein IGF2BP1
Coyne, S. M., Hwang, G.-H., Wu, T., Hossain, M. A., Vinjamur, D. S., Starrs, M. M., Zeng, J., Andresen, F., Gutierrez, A. M., Shimamura, A., et al. (2026) · Blood · doi:10.1182/blood.2025031840 · Cited by 5
Highly discriminative globin gene activation by the noncanonical BAF chromatin remodeling complex
Bagchi, A., Billakanti, S., Shehu, V., Farrell, K. M., Cotteta, S. A., Godfrey, B. N., Alpert, M., Zeranski, J. F., Budinich, K. A., Geng, Z., et al. (2025) · Blood · doi:10.1182/blood.2025029429 · Cited by 3
Discovery of a Novel DNMT1 Inhibitor with Improved Efficacy in Treating β‐Thalassemia
Shen, Y., Wei, J., Tang, S., Wu, D., Zong, L., Ma, S., Xiong, Q., Gong, R., Xu, S., Peng, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202513469 · Cited by 4
p27Kip1 regulates γ-globin production
Balbin-Cuesta, G., Drysdale, C. M., Kerpet, C., Yu, L., Myers, G., Lin, Z., McGee, B. M., Friedman, A. D., Liu, X., Singh, S. A., et al. (2025) · Blood · doi:10.1182/blood.2025028895 · Cited by 5
Traxler, E. A., Hotan, Q., Shao, Y., Komar, C. A., Chen, Q., Saari, M. S., Thrasher, A. J., Yang, S., Qin, K., Wang, M. Y., et al. (2026) · Blood · doi:10.1182/blood.2025030137 · Cited by 3
Reduced cyclin D3 expression in erythroid cells protects against malaria
Marini, M. G., Mingoia, M., Steri, M., Tsamesidis, I., Idda, M. L., Manca, A., D’Avino, C., Virdis, F., Lodde, V., Mulas, A., et al. (2026) · Nature · doi:10.1038/s41586-026-10110-9 · Cited by 5
“The constructs were then tested for their ability to activate expression of luciferase in human umbilical cord-derived erythroid progenitor 2 (HUDEP-2) cells, a model that can recapitulate the development of erythroid cells 21 .”
Boccacci, Y., Dumont, N., Doyon, Y., & Laganière, J. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.07.007 · Cited by 3
miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation
Simbula, M., Manchinu, M. F., Mingoia, M., Pala, M., Asunis, I., Caria, C. A., Perseu, L., Shah, M., Crossley, M., Moi, P., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.09.002 · Cited by 3
“However, these cells tend to have high background levels of HbF. 71 Insummary,miRNAsequencingoffetalliver murinecellsshowedthat miR-365-3p is overexpressed in BCL11A -null mice.”
BackgroundMethodRousseau, G. F., Mazurier, C., & Douay, L. (2016) · ISBT Science Series · doi:10.1111/voxs.12235 · Cited by 3
An Introduction to Erythropoiesis Approaches
Lloyd, J. A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7428-3_1 · Cited by 6
Erythrocyte–Plasmodium interactions: genetic manipulation of the erythroid lineage
Tétard, M., Peterson, N. A., & Egan, E. S. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102221 · Cited by 3
Kim, S., Jo, K., Park, J., Shin, A., Kurita, R., Nakamura, Y., Kweon, S., & Baek, E. J. (2023) · Transfusion · doi:10.1111/trf.17394 · Cited by 3
“Some reports have suggested that the safety issue may be resolved by removing the residual nucleated cells using a leukoreduction filter or γ-irradiation.(4,10,11) Although the processes can be applied to RBC products generated from primary hematopoietic stem cells (HSCs), it is still unknown whether those can be appl…”
BackgroundMethodSelf-citationCreg1 Regulates Erythroid Development via TGF‐β/Smad2‐Klf1 Axis in Zebrafish
Han, X. J., He, W., Liang, D., Liu, X., Zhou, J., de Thé, H., Zhu, J., & Yuan, H. (2024) · Advanced Science · doi:10.1002/advs.202402804 · Cited by 3
Shin, A., Park, S. A., Kim, J. Y., & Baek, E. J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1474631 · Cited by 3
Metadata
- Authors
- Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K., & Nakamura, Y.
- Affiliations
- RIKEN BioResource Research Center (JP)
- Kyushu University (JP)
- Corresponding author
- Nakamura, Yukio
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-22
- Volume
- 8
- Issue
- 3
- Pages
- e59890
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3606290
- OpenAlex
- W1974742081
- Cited by
- 418
- References
- 28
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 34 · 2023: 36 · 2022: 35 · 2021: 48 · 2020: 45 · 2019: 31 · 2018: 32 · 2017: 24 · 2016: 25 · 2015: 10 · 2014: 8 · 2013: 8
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- RIKEN
- RIKEN Brain Science Institute
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- erythroid progenitor cells, immortalized cell lines, in vitro erythropoiesis, blood transfusion, erythroid differentiation
- MeSH terms
- Cell Nucleus, Erythrocytes, Erythropoiesis, Humans, Erythroid Precursor Cells, Erythrocyte Transfusion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.